Skip to main content

Month: March 2020

BioELife Corp Adds Pharmaceutical Industry Veteran to Advisory Board for Manufacturing & Distribution of Products to Help Defend Against Viral (COVID-19) and Bacterial Contamination

HENDERSON, Nev., March 23, 2020 (GLOBE NEWSWIRE) — BioELife Corp. (OTC QB: LITH) (the “Company”) is pleased to announce that William (Bill) Marciniak is joining its Advisory Board of external experts to assist the Company in its strategic development. Mr. Marciniak brings over 35 years of pharmaceutical and manufacturing experience to help BioELife expand its product line, manufacturing and distributor relationships.As a co-founder of RxElite, Mr. Marciniak achieved great success developing and producing albuterol and ipratropium. After acquiring the appropriate ANDA certification for each product, contracting with the top manufacturers and leading the distribution efforts, RxElite captured 33% market share in just 18 months. Their clients were the top wholesalers, distributors and pharmacy chains in America.  RxElite was eventually...

Continue reading

Alector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors

SOUTH SAN FRANCISCO, Calif., March 23, 2020 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC) today announced the addition of Paula Hammond, Ph.D., to the Company’s Board of Directors. Dr. Hammond is the David H. Koch Chair Professor of Engineering and Department Head, Chemical Engineering at the Massachusetts Institute of Technology (MIT), a member of MIT’s Koch Institute for Integrative Cancer Research and a founding member of the MIT Institute for Soldier Nanotechnology.“At Alector, we are building a leading biotechnology company, and as part of those efforts, we are partnering with top scientists, drug developers and business leaders to advise us and support our ambitious goal of curing neurodegeneration,” said Arnon Rosenthal, Ph.D., Chief Executive Officer of Alector. “Paula brings more than 25 years of scientific excellence...

Continue reading

Westport Fuel Systems Announces the Temporary Suspension of Production in Cherasco and Albinea, Italy

VANCOUVER, British Columbia, March 23, 2020 (GLOBE NEWSWIRE) — Pursuant to the Italian Government’s decree issued on March 22, 2020 regarding COVID-19, Westport Fuel Systems Inc. (“Westport Fuel Systems” or the “Company”) (TSX:WPRT / Nasdaq:WPRT) today announced it will temporarily suspend production at its facilities in Cherasco and Albinea, Italy. The directive is in effect until April 03, 2020. The temporary suspension of the Company’s production in Brescia, Italy announced on March 16, 2020, will be extended to align with this latest directive.“The health and well-being of our global team of employees continues to be our utmost priority”, said David M. Johnson, Chief Executive Officer of Westport Fuel Systems. “Our Italian team has shown tremendous resilience during this difficult time and we support government efforts to act...

Continue reading

THE CHEFS’ WAREHOUSE ADOPTS LIMITED DURATION STOCKHOLDER RIGHTS AGREEMENT

RIDGEFIELD, Conn., March 23, 2020 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ:CHEF) (the “Company”), a premier distributor of specialty food products in North America, today announced that it has adopted a 364-day duration stockholder rights agreement (the “Rights Agreement”), effective March 22, 2020.The Rights Agreement is similar to stockholder rights plans adopted by other public companies, and is intended to promote the fair and equal treatment of all Company stockholders and ensure that no person or group can gain control of the Company through open market accumulation or other tactics potentially disadvantaging the interests of all stockholders without paying an appropriate control premium to deliver sufficient value for all Company stockholders. The Company’s Board of Directors (the “Board”) has taken note in particular...

Continue reading

Medexus Provides a Business Update and Outlines Response to COVID-19 Pandemic

TORONTO, CHICAGO and MONTREAL, March 23, 2020 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSX-V: MDP, OTCQB: PDDPF) today provided an update to its shareholders reaffirming the strength of its business and outlining the measures it has taken in light of the COVID-19 healthcare crisis.Since December 31, 2019, the outbreak of the novel strain of coronavirus, specifically identified as “COVID-19”, has resulted in governments worldwide enacting emergency measures to combat the spread of the virus, including the implementation of travel bans, quarantine periods and social distancing. The World Health Organization has declared COVID-19 a pandemic and, as the crisis deepens in North America, Medexus is actively assessing and responding where possible to its potential impact on the Company’s business.“Our...

Continue reading

Kimberly Lathroum Joins Arcutis as Vice President of Marketing

WESTLAKE VILLAGE, Calif., March 23, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Kimberly Lathroum has joined the company as Vice President of Marketing. In this new role, Ms. Lathroum will be responsible for all of Arcutis’ marketing efforts as the Company prepares for the potential future commercialization of its product candidates.“Kimberly is an exceptional marketing and commercialization executive with over 18 years of experience in the biopharmaceutical industry, 10 of which have been specifically focused on the dermatology market,” said Frank Watanabe, Arcutis’ President and Chief Executive...

Continue reading

HC2 Holdings Provides Business Update in Response to COVID-19 Impact

NEW YORK, March 23, 2020 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (“HC2” or the “Company”) (NYSE: HCHC), a diversified holding company, today provided an update on the operations of its holding company and operating subsidiaries in response to the impact of the COVID-19 outbreak, including steps being taken to ensure employee safety during the continuing COVID-19 outbreak.HC2’s holding company and its subsidiaries continue to operate, mostly uninterrupted, and the management teams have been implementing their business continuity plans to ensure that their businesses are able to operate and to protect the health and safety of their employees, clients and other business partners as the COVID-19 outbreak continues.“Across our holding company and operating subsidiaries we are taking steps to ensure that we are able to operate as best as...

Continue reading

Beazley Breach Briefing: Ransomware remains top cyber security threat for businesses

New York, March 23, 2020 (GLOBE NEWSWIRE) — Ransomware attacks skyrocketed in 2019, according to the latest Beazley Breach Briefing, an annual update on cyber trends produced by leading cyber insurer Beazley.Beazley’s in-house team of breach experts, Beazley Breach Response (BBR) Services, reported the number of ransomware attack notifications against clients increased by 131% compared to 2018. With the growth in frequency, the sums demanded by cybercriminals also increased exponentially, sometimes reaching seven or even eight figures.Cyber criminals’ methods of attack continue to evolve, too. The two most common forms of attack to deploy ransomware are phishing emails and breaching poorly secured remote desktop protocol (RDP). RDP enables employees to access their work computer desktops or company’s primary server from home with...

Continue reading

Covid-19 update and 2019 Final Dividend

  23 March 2020G4S plcCovid-19 Update and 2019 Final DividendG4S, the leading global security company provides the following update on Covid-19.As reported on 11 March 2020, when G4S announced its 2019 preliminary full year results, the financial impact of Covid-19 has not been material in the context of the Group’s year-to-date performance.The Board notes that, in the period since 11 March 2020, the spread of the virus to countries outside Asia has accelerated and the World Health Organisation has declared Covid-19 a global pandemic.  Countermeasures that are being introduced by national governments have escalated rapidly with potentially significant implications for the level of economic activity across a wide range of business sectors and geographic markets.G4S is working with employees, customers, suppliers, regulators and governments...

Continue reading

Transactions by persons discharging managerial responsibilities and/or persons closely associated

COMPANY ANNOUNCEMENT 14/2020 – 23 MARCH 2020Pursuant to article 19 of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse Royal Unibrew A/S has received notification of the below transactions related to shares in Royal Unibrew A/S made by persons discharging managerial responsibilities in Royal Unibrew A/S and/or persons closely related with them.Royal Unibrew A/S hereby makes public pursuant to article 19(3) of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse the information on the below transaction related to shares in Royal Unibrew A/S made by persons discharging managerial responsibilities in Royal Unibrew A/S and/or persons closely related with them.1Details of the person discharging managerial responsibilities/person closely associateda)NameMargit Risager...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.